Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingShort-Term Debt repayments
Ratios

China Pharma Holdings (CPHI) Long-Term Debt Issuances: 2010-2025

Historic Long-Term Debt Issuances for China Pharma Holdings (CPHI) over the last 9 years, with Sep 2025 value amounting to -$44,176.

  • China Pharma Holdings' Long-Term Debt Issuances fell 745.56% to -$44,176 in Q3 2025 from the same period last year, while for Sep 2025 it was $260,299, marking a year-over-year increase of 846.68%. This contributed to the annual value of $27,353 for FY2024, which is 10.53% down from last year.
  • According to the latest figures from Q3 2025, China Pharma Holdings' Long-Term Debt Issuances is -$44,176, which was down 115.19% from $290,886 recorded in Q2 2025.
  • China Pharma Holdings' Long-Term Debt Issuances' 5-year high stood at $932,114 during Q3 2022, with a 5-year trough of -$3.7 million in Q4 2021.
  • For the 3-year period, China Pharma Holdings' Long-Term Debt Issuances averaged around $32,767, with its median value being $6,852 (2024).
  • Per our database at Business Quant, China Pharma Holdings' Long-Term Debt Issuances plummeted by 8,352.90% in 2021 and then spiked by 4,145.27% in 2025.
  • Over the past 5 years, China Pharma Holdings' Long-Term Debt Issuances (Quarterly) stood at -$3.7 million in 2021, then surged by 100.19% to $6,848 in 2022, then spiked by 100.80% to $6,945 in 2023, then fell by 1.34% to $6,802 in 2024, then slumped by 745.56% to -$44,176 in 2025.
  • Its Long-Term Debt Issuances was -$44,176 in Q3 2025, compared to $290,886 in Q2 2025 and $6,787 in Q1 2025.